“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051.


Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019
Journal Issue: March

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051.. Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057.
Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018
Year: 2018


“Adult-onset asthma: is it really different?” Selma B. de Nijs, Lisette N. Venekamp and Elisabeth H. Bel. Eur Respir Rev 2013; 22: 44–52.
Source: Eur Respir Rev 2013; 22: 193
Year: 2013


“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444.
Source: Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017
Year: 2018


“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021.
Source: Eur Respir Rev, 28 (154) 195096; 10.1183/16000617.5096-2019
Year: 2019


“Idiopathic inflammatory myopathies and the lung.” Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216–238.
Source: Eur Respir Rev 2015; 24: 545
Year: 2015


“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647.
Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019
Year: 2020



“Contact investigation for tuberculosis: a systematic review and meta-analysis.” Gregory J. Fox, Simone E. Barry, Warwick J. Britton and Guy B. Marks. Eur Respir J 2013; 41: 140–156.
Source: Eur Respir J 2015; 46: 578
Year: 2015


“Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing.” Denis E. O'Donnell, Amany F. Elbehairy, Azmy Faisal, Katherine A. Webb, J. Alberto Neder and Donald A. Mahler. Eur Respir Rev 2016; 25: 333–347.
Source: Eur Respir Rev 2016; 25: 513
Year: 2016



“Advanced medical interventions in pleural disease.” Rahul Bhatnagar, John P. Corcoran, Fabien Maldonado, David Feller-Kopman, Julius Janssen, Philippe Astoul and Najib M. Rahman. Eur Respir Rev 2016; 25: 199–213.
Source: Eur Respir Rev 2016; 25: 360
Year: 2016


“Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?” Wim A. Wuyts, Alberto Cavazza, Giulio Rossi, Francesco Bonella, Nicola Sverzellati and Paolo Spagnolo. Eur Respir Rev 2014; 23: 308–319.
Source: Eur Respir Rev 2014; 23: 537
Year: 2014


“Haemoptysis due to pulmonary venous stenosis.” Silke Braun, Ivan Platzek, Klaus Zöphel, Matthias Weise, Martin Kolditz, Michael Halank and Gert Hoeffken. Eur Respir Rev 2014; 23: 170–179.
Source: Eur Respir Rev 2014; 23: 399
Year: 2014


“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.
Source: Eur Respir J, 52 (4) 1850230; 10.1183/13993003.50230-2018
Year: 2018


“Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.” Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha and Alvar Agusti. Eur Respir J 2017; 49: 1700214.
Source: Eur Respir J, 49 (6) 1750214; 10.1183/13993003.50214-2017
Year: 2017


“The effect of exacerbation history on outcomes in the IMPACT trial.” David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise and Gerard J. Criner. Eur Respir J 2020; 55: 1901921.
Source: Eur Respir J, 55 (6) 1951921; 10.1183/13993003.51921-2019
Year: 2020



“Characterisation of patients with interstitial pneumonia with autoimmune features.” Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. Eur Respir J 2016; 47: 1767–1775.
Source: Eur Respir J, 49 (5) 1551565; 10.1183/13993003.51565-2015
Year: 2017


“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784.
Source: Eur Respir J 2016; 48: 593
Year: 2016


“2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.” Brian L. Graham, Vito Brusasco, Felip Burgos, Brendan G. Cooper, Robert Jensen, Adrian Kendrick, Neil R. MacIntyre, Bruce R. Thompson and Jack Wanger. Eur Respir J 2017; 49: 1600016.
Source: Eur Respir J, 52 (5) 1650016; 10.1183/13993003.50016-2016
Year: 2018


“Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833.
Source: Eur Respir J 2016; 47: 692
Year: 2016


“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185.
Source: Eur Respir J 2016; 47:1892
Year: 2016


“Rapid diagnosis of primary ciliary dyskinesia: cell culture, soft computing analysis.” Massimo Pifferi Andrew Bush Francesca Montemurro Giovanni Pioggia Martina Piras Gennaro Tartarisco Maria Di Cicco Iolanda Chinellato Angela M. Cangiotti, Attilio L. Boner. Eur Respir J 2013; 41: 960–965.
Source: Eur Respir J 2013; 42: 1162
Year: 2013